Polymorphisms in TSHR and IL1RN genes and the risk and prognosis of Hashimoto's thyroiditis

Autoimmunity

Volumn 47, Issue 2, 2014, Pages 113-118

  Zaaber, Ines ^a   Mestiri, Souhir ^a   Marmouch, Hela ^b   Mahjoub, Silvia ^b   Abid, Nabil ^c   Hassine, Mohsen ^c   Bel Hadj Jrad Tensaout, Besma ^a   Said, Khaled ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Anti thyroglobulin antibody; Anti thyroid peroxidase antibody; HT; IL1RN; TSHR

Indexed keywords

ADULT; ALLELES; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, THYROTROPIN; SEVERITY OF ILLNESS INDEX; THYROTROPIN;

EID: 84894564320     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.866101     Document Type: Article

References (37)

1. Weetman, A. P. 1996. Chronic autoimmune thyroiditis. In Werner and Ingbars the Thyroid. L. E. Braverman and R. D. Utiger, eds. Lippincott-Raven, Philadelphia. p. 738-748.
2. Davies, T. F. 1996. The pathogenesis of Graves disease. In The Thyroid: A Fundamental Textbook, 7th ed. L. E. Braverman and R. D. Utiger, eds. Lippincott-Press, Philadelphia. p. 525-536.
3. Ban, Y., and Y. Tomer. 2003. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves and Hashimotos diseases. Autoimmunity. 36: 367-379.
4. Tomer, Y., G. Barbesino, M. Keddache, et al. 1997. Mapping of a major susceptibility locus for Graves disease (GD-1) to chromosome 14q31. J. Clin. Endocrinol. Metab. 82: 1645-1648.
5. Davies, T. F., T. Ando, R. Y. Lin, et al. 2005. Thyrotropin receptorassociated diseases: From adenomata to Graves disease. J. Clin. Invest. 115: 1972-1983.
6. Tonacchera, M., and A. Pinchera. 2000. Thyrotropin receptor polymorphisms and thyroid diseases. J. Clin. Endocrinol. Metab. 85: 2637-2639.
7. Gabriel, E. M., E. R. Bergert, C. S. Grant, et al. 1999. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J. Clin. Endocrinol. Metab. 84: 3328-3335.
8. Muhlberg, T., K. Herrmann, W. Joba, et al. 2000. Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of human thyrotropin receptor in a European Caucasian population. J. Clin. Endocrinol. Metab. 85: 2640-2643.
9. Ban, Y., D. A. Greenberg, E. S. Concepcion, and Y. Tomer. 2002. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves disease. Thyroid. 12: 1079-1183.
10. Ajjan, R. A., C. Findlay, R. A. Metcalfe, et al. 1998. The modulation of the human sodium iodide symporter activity by Graves disease sera. J. Clin. Endocrinol. Metab. 83: 1217-1221.
11. Dinarello, C. A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8: 253-265.
12. Tarlow, J. K., A. I. Blakemore, A. Lennard, et al. 1993. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91: 403-404.
13. Vamvakopoulos, J., C. Green, and S. Metcalfe. 2002. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 32: 2988-2996.
14. Vamvakopoulos, J., C. Taylor, G. J. Morris-Stiff, et al. 2002. The interleukin-1 receptor antagonist gene: A single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Euro. J. Immunogenet. 29: 337-340.
15. Steinkasserer, A., K. Koelble, and R. B. Sim. 1991. Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN). Nucl. Acids Res. 19: 5095.
16. Danis, V. A., M. Millington, V. J. Hyland, and D. Grennan. 1995. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99: 303-310.
17. Hurme, M., and S. Santtila. 1998. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur. J. Immunol. 28: 2598-2602.
18. Blakemore, A. I. F., P. F. Watson, A. P. Weetnan, and G. W. Duff. 1995. Association of Graves disease with an allele of interleukin 1 receptor antagonist gene. J. Clin. Endocrinol. Metab. 80: 111-115.
19. Fang, X. M., S. Schroder, A. Hoeft, and F. Stuber. 1999. Comparison of two polymorphisms of the interleukin 1 gene family: Interleukin 1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit. Care. Med. 27: 1330-1334.
20. Olerup, O., and H. Zetterquist. 1992. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39: 225-235.
21. Settin, A., H. Abdel-Hady, R. El-Baz, and I. Saber. 2007. Gene polymorphisms of TNF-A (-308), IL-10(-1082), IL-6(-174), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr. Cardiol. 28: 363-371.
22. Yin, X., R. Latif, R. Bahn, et al. 2008. Influence of the TSH receptor gene on susceptibility to Graves disease and Graves ophthalmopathy. Thyroid. 18: 1201-1206.
23. Matakidou, A., N. Hamel, S. Popat, et al. 2004. Risk of nonmedullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. Carcinogenesis. 25: 369-373.
24. Inoue, N., M. Watanabe, Y. Katsumata, et al. 2013. Different genotypes of a functional polymorphism of the TSHR gene are associated with the development and severity of Graves and Hashimotos diseases. Tissue Antigens. 82: 288-290.
25. Liu, L., H. Q. Wu, Q. Wang, et al. 2012. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Endocr. J. 59: 717-723.
26. Yan, L., Y. L. Yu, J. Yang, et al. 2012. Association of interleukin-17A and-17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity. 45: 533-539.
27. Inoue, N., M. Watanabe, M. Wada, et al. 2013. IL-10-592A/C polymorphism is associated with severity of Hashimotos disease. Cytokine. 64: 370-374.
28. Inoue, N., M. Watanabe, M. Morita, et al. 2011. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin. Exp. Immunol. 163: 318-323.
29. Kammoun-Krichen, M., N. Bougacha-Elleuch, K. Makni, et al. 2007. Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur. Cytokine Netw. 18: 196-200.
30. Peeters, R. P., H. Van Toor, W. Klootwijk, et al. 2003. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J. Clin. Endocrinol. Metab. 88: 2880-2888.
31. Liu, R. D., R. X. Chen, W. R. Li, et al. 2012. The Glu727 allele of thyroid stimulating hormone receptor gene is associated with osteoporosis. N. Am. J. Med. Sci. 4: 300-304.
32. Van der Deure, W. M., A. G. Uitterlinden, A. Hofman, et al. 2008. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: The Rotterdam Study. Clin. Endocrinol. 68: 175-181.
33. Tomer, Y., and T. F. Davies. 2003. Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr. Rev. 24: 694-717.
34. Luotola, K., P. Mantula, J. Salmi, et al. 2001. Allele 2 of interleukin-1 receptor antagonist gene increases the risk of thyroid peroxidase antibodies in subacute thyroiditis. APMIS 109: 454-460.
35. Blakemore, A. I. F., J. K. Tarlow, M. J. Cork, et al. 1994. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37: 1380-1385.
36. Bioque, G., G. Bouma, J. B. A. Crusius, et al. 1996. Evidence for genetic heterogeneity in IBD The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110.
37. Tarlow, J. K., M. J. Cork, F. E. Clay, et al. 1997. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br. J. Dermatol. 136: 147-148.